Panic Disorder Caffeine Study Found No Correlation With Benzodiazepine Use

A case-control study found greater caffeine consumption in panic disorder but no correlation between caffeine intake and reported sedative use.

The measured associations

Sixty-five patients with panic disorder and 66 controls completed caffeine assessments. Patients consumed more caffeine and reported less sleep. Within the patient group, caffeine intake was not correlated with benzodiazepine or sedative medication use, panic attacks, or depression comorbidity.

A null correlation does not reveal the mechanism

The modest sample, self-reported recent consumption, and cross-sectional design leave uncertainty about timing, tolerance, and individual sensitivity. The result does not establish that caffeine counteracts benzodiazepines, that medication caused increased caffeine use, or that no interaction is possible. The authors discussed tolerance and patient subtypes as possible explanations, rather than proven mechanisms. The paper helps distinguish an appealing self-medication story from what the actual data demonstrated. Individual stimulant and sedative effects still require exposure and symptom timelines.

Source paper

Original analysis of the supplied journal article, identified as PMC6882139.

Related research

• Dementia Visit Study Found Similar Combined Benzodiazepine and Z-Drug Reporting
• Northern California Pandemic Study Found Lower Benzodiazepine Fills After Accounting for Prior Trends